Abstract |
Viscolin, a major active component in a chloroform extract of Viscum coloratum, has antioxidative and anti-inflammatory properties. We focused on its effects on the expression of vascular cell adhesion molecule-1 (VCAM-1) in tumor necrosis factor-α (TNF-α)-treated human umbilical vein endothelial cells (HUVECs). The TNF-α-induced expression of VCAM-1 was significantly reduced by respectively 38±7 or 34±16% when HUVECs were pretreated with 10 or 30μM viscolin, as shown by Western blotting, and was also significantly reduced by pretreatment with the antioxidants N-acetylcysteine, diphenylene iodonium chloride, and apocynin. Viscolin also reduced TNF-α-induced VCAM-1 mRNA expression and promoter activity, decreased reactive oxygen species (ROS) production, nicotinamide adenine dinucleotide phosphate ( NADPH) oxidase activity, and significantly reduced the binding of monocytes to TNF-α-stimulated HUVECs. The attenuation of TNF-α-induced VCAM-1 expression and cell adhesion was partly mediated by a decrease in JNK phosphorylation. Furthermore, viscolin reduced VCAM-1 expression in the aorta of TNF-α-treated mice in vivo. Taken together, these data show that viscolin inhibits TNF-α-induced JNK phosphorylation, nuclear translocation of NF-κB p65, and ROS generation and thereby suppresses VCAM-1 expression, resulting in reduced adhesion of leukocytes. These results also suggest that viscolin may prevent the development of atherosclerosis and inflammatory responses.
|
Authors | Chan-Jung Liang, Shu-Huei Wang, Yung-Hsiang Chen, Shih-Sheng Chang, Tong-Long Hwang, Yann-Lii Leu, Ying-Chih Tseng, Chi-Yuan Li, Yuh-Lien Chen |
Journal | Free radical biology & medicine
(Free Radic Biol Med)
Vol. 51
Issue 7
Pg. 1337-46
(Oct 01 2011)
ISSN: 1873-4596 [Electronic] United States |
PMID | 21767632
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents
- Biphenyl Compounds
- RNA, Messenger
- Reactive Oxygen Species
- Transcription Factor RelA
- Tumor Necrosis Factor-alpha
- Vascular Cell Adhesion Molecule-1
- viscolin
- NADPH Oxidases
- MAP Kinase Kinase 4
- Propane
|
Topics |
- Animals
- Anti-Inflammatory Agents
(pharmacology)
- Aorta
(cytology, drug effects, metabolism)
- Atherosclerosis
(prevention & control)
- Biphenyl Compounds
(pharmacology)
- Blotting, Western
- Cell Adhesion
(drug effects)
- Dose-Response Relationship, Drug
- Down-Regulation
- Endothelial Cells
(cytology, drug effects, metabolism)
- Endothelium, Vascular
(cytology, drug effects, metabolism)
- Human Umbilical Vein Endothelial Cells
(drug effects, metabolism)
- Humans
- MAP Kinase Kinase 4
(antagonists & inhibitors, genetics, metabolism)
- Male
- Mice
- Mice, Inbred C57BL
- Monocytes
(drug effects)
- NADPH Oxidases
(antagonists & inhibitors, genetics, metabolism)
- Phosphorylation
(drug effects)
- Propane
(analogs & derivatives, pharmacology)
- RNA, Messenger
(analysis)
- Reactive Oxygen Species
(antagonists & inhibitors, metabolism)
- Transcription Factor RelA
(antagonists & inhibitors, genetics, metabolism)
- Tumor Necrosis Factor-alpha
(adverse effects, pharmacology)
- Vascular Cell Adhesion Molecule-1
(biosynthesis)
- Viscum
(chemistry)
|